Q2 Solutions 理解,将有前景的候选药物推向市场需要一个精心规划的策略,该策略包含灵敏、具体且经验证的分析,为开发决策提供信息。因此,我们训练有素的科学家应用前沿技术、自动化平台和最先进的技术,以支持广泛的生物分析服务和 ADME 服务。
Q2 Solutions 全球网络提供从支持药物代谢和药代动力学研究的高通量 ADME 筛选服务和人类清除率预测,到支持临床安全性的药物间相互作用检测和代谢物谱分析的解决方案,以支持药物发现和开发的每个阶段。
我们的生物分析服务包括:
除了以下各节中详述的特定服务外,Q2 Solutions 可以为发现和监管阶段整套内容提供捆绑服务,以便在开发流程的每个步骤做出决策。
This brochure highlights the specialty immunoassays performed by Rules-Based Medicine, a Q2 Solutions company. RBM provides an extensive menu of quantitative protein biomarkers, including multiplexed...
The increasing complexity of large molecule therapeutics has driven the need for additional approaches to quantitation in regulated bioanalysis where challenges with traditional ligand binding assays...
Presented at WRIB 2024 by Jing Liu, Principle Scientist, this poster looks at the challenges posed by XPro1595, a pegylated, engineered form of soluble human Tumor Necrosis Factor alpha (TNF alpha)...